Apogee Therapeutics, Inc. (APGE)
NASDAQ·Healthcare·Biotechnology
$134.28
+0.13%
Mkt Cap $8.31B
Analyst Ratings
Buy
9
Hold
10
Sell
0
Price Target (22 analysts)
$122.75
Range $81.00 – $140.00
Implied Upside
-8.6%
Consensus $122.75 vs current $134.28
NASDAQ·Healthcare·Biotechnology
$134.28
+0.13%
Mkt Cap $8.31B
Buy
9
Hold
10
Sell
0
Price Target (22 analysts)
$122.75
Range $81.00 – $140.00
-8.6%
Consensus $122.75 vs current $134.28